Pearl Therapeutics
Developing innovative combination therapies for respiratory health, enhancing safety, efficacy, and accessibility for all.
Developing innovative combination therapies for respiratory health, enhancing safety, efficacy, and accessibility for all.
Pearl Therapeutics is a biotechnology startup dedicated to developing innovative combination therapies for respiratory health, with a focus on enhancing safety, efficacy, and accessibility for all. Founded in 2006, the company is currently concentrating on creating advanced inhaled treatments accessible to a wide range of patients through familiar metered dose inhalers. Their offerings are geared towards addressing common respiratory conditions, particularly chronic obstructive pulmonary disease, with a goal of providing alternatives that better satisfy patient and healthcare professional needs. As of 01 April 2013, Pearl Therapeutics secured a significant $41.73M in Venture Round investment from notable firms including New Leaf Venture Partners, 5AM Ventures, Vatera Healthcare Partners, and Clarus Ventures. Operating as a privately held entity, Pearl Therapeutics is led by an experienced team specializing in respiratory product development, positioning the company to improve clinical outcomes for respiratory therapies.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $41.73M | 4 |
|
01 Apr 2013 |
| Series D | $65.00M | 4 |
|
13 Nov 2012 |
| Private Equity Round | $23.27M | 4 |
|
01 Oct 2012 |
| Series C | $69.00M | 3 |
|
19 Oct 2010 |
| Series C | $15.00M | 3 |
|
01 Feb 2010 |
No recent news or press coverage available for Pearl Therapeutics.
We care about your data, and we'd love to use cookies make your experience better.
